Thanks. Wanted a concise PDF with links to the peer analysis data. People can form their own opinions after watching the videos.
Steep learning curve ahead on the oncology market and the fundamentals of Bisantrene. Once people do the work to understand these two key things they will see what I see in terms of upside probability.
RAC Upside - promising forgotten cancer drug that works, page-4
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.63 |
Change
-0.030(1.81%) |
Mkt cap ! $278.6M | |||
| Open | High | Low | Value | Volume |
| $1.67 | $1.67 | $1.62 | $142.3K | 86.99K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5970 | $1.63 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.64 | 2300 | 1 |
View Market Depth
| Last trade - 13.50pm 10/09/2024 (20 minute delay) ? |
| RAC (ASX) Chart |